FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

15851411000001106: Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56303601000001111 Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56303701000001118 Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Oxycodone 40mg / Naloxone 20mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Naloxone hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start